Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
125.18B
Market cap125.18B
Price-Earnings ratio
27.50
Price-Earnings ratio27.50
Dividend yield
2.87%
Dividend yield2.87%
Average volume
9.88M
Average volume9.88M
High today
$98.78
High today$98.78
Low today
$97.51
Low today$97.51
Open price
$98.50
Open price$98.50
Volume
1.33M
Volume1.33M
52 Week high
$106.33
52 Week high$106.33
52 Week low
$79.55
52 Week low$79.55

Stock Snapshot

The current Medtronic(MDT) stock price is $97.64, with a market capitalization of 125.18B. The stock trades at a price-to-earnings (P/E) ratio of 27.50 and offers a dividend yield of 2.9%.

As of 2026-02-24, Medtronic(MDT) stock has fluctuated between $97.51 and $98.78. The current price stands at $97.64, placing the stock +0.1% above today's low and -1.2% off the high.

The Medtronic(MDT)'s current trading volume is 1.33M, compared to an average daily volume of 9.88M.

During the past year, Medtronic(MDT) stock moved between $79.55 at its lowest and $106.33 at its peak.

During the past year, Medtronic(MDT) stock moved between $79.55 at its lowest and $106.33 at its peak.

MDT News

TipRanks 3h
MiniMed announces launch of IPO roadshow

MiniMed Group (MMED), a subsidiary of Medtronic (MDT), announced that it has launched a roadshow for the initial public offering of 28M shares of its common sto...

Bloomberg 3h
Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO - Bloomberg

...

Medtronic Diabetes Business MiniMed Seeks $784 Million in US IPO - Bloomberg
The Motley Fool 2d
Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash

The company operates in a field where spending often isn't optional. The terms "dividend" and "healthcare stock" usually aren't mentioned in the same sentence....

Dividend Medtech Giant Medtronic Is Built to Survive Any Market Crash

Analyst ratings

63%

of 35 ratings
Buy
62.9%
Hold
37.1%
Sell
0%

More MDT News

Nasdaq 3d
The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic

Key Points Medtronic is a large and diversified medical device company with a history of innovation. It has also consistently raised its dividend and is closi...

The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic
Simply Wall St 6d
Assessing Medtronic’s Valuation After Q3 2026 Beat And Ongoing Robotics And Cardiovascular Momentum

Medtronic (MDT) just released its Q3 2026 results, reporting revenue ahead of expectations and solid contributions from its cardiovascular and diabetes business...

Assessing Medtronic’s Valuation After Q3 2026 Beat And Ongoing Robotics And Cardiovascular Momentum
TipRanks 6d
Medtronic price target lowered to $103 from $107 at Truist

Truist analyst Richard Newitter lowered the firm’s price target on Medtronic (MDT) to $103 from $107 and keeps a Hold rating on the shares. The firm notes the c...

Benzinga 6d
Medtronic Analysts Cut Their Forecasts After Q3 Earnings

Medtronic PLC (NYSE:MDT) posted better-than-expected earnings for the third quarter on Tuesday. The company posted adjusted EPS of $1.36, beating market estimat...

Medtronic Analysts Cut Their Forecasts After Q3 Earnings
TipRanks 6d
Medtronic: Solid Quarter but Limited Growth Visibility Justifies Hold Rating

Medtronic, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Danielle Antalffy from UBS maintained a Hold rating on the s...

Benzinga 7d
Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth

Adjusted earnings of $1.36 per share also beat expectations of $1.33. Segment Performance Neuroscience Portfolio revenue of $2.558 billion, an increase of 4.1...

Medtronic Reaffirms 2026 Outlook As Heart and Diabetes Units Drive Growth
Benzinga 7d
Gold Down 3%; Medtronic Earnings Top Views

U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite falling more than 50 points on Tuesday. The Dow traded down 0.01% to 49,499.5...

Gold Down 3%; Medtronic Earnings Top Views

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.